Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube

✍ Scribed by Ignacio Romero Noguera; Charlotte C. Sun; Russell R. Broaddus; Donna Branham; Charles F. Levenback; Pedro T. Ramirez; Anil K. Sood; Robert L. Coleman; David M. Gershenson

• Book ID: 113964084
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 168 KB
• Volume: 125
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2012.02.034